dublin, October 2, 2023 /PRNewswire/ — “Protein Labeling Market Size, Share and Trend Analysis Report (By Product (Reagents, Kits), By Method, By Application (Mass Spectrometry, Cell-Based Assays), By Region, Segment Forecast, 2023-2030”) Report added ResearchAndMarkets.com Recruitment.
Global Protein Labeling Market Is Ready to Reach $4.11 billion Achieved at a CAGR of 7.44% by 2030
Protein labeling is undergoing a major transformation due to increased interest in post-translational modification (PTM) research. Application of advanced quantitative methods such as iodoTMTzero Label Reagent facilitates efficient detection of PTMs and advances the market. New technology and enhanced products will further fuel growth.
Biomedical research revolutionizes global protein labeling market
Biomedical research is at the forefront driving the growth of the global protein labeling market. His proliferation of PTM research, spurred by breakthroughs in protein expression quantification and innovative tagging strategies, is a pivotal factor.
Among these strategies, the use of spin labels in combination with electron paramagnetic resonance spectroscopy (SDSL-EPR) has expanded the possibilities of protein structure studies. Investments from the private and government sectors in proteomics and genomics research are driving market expansion.
Innovative technology and increased funding expand market potential
Continuing innovations such as spin labels in site-specific protein labeling are increasing market potential. Proteomic profiling, an essential element in the study of cells, tissues, and organisms, relies on effective protein labels for separation and analysis, making this market essential for proteomics and genomics research and development. I am.
Growing investment in life sciences research is increasing our understanding of the origins and progression of diseases, expanding market scope and potential.
Increasing investment in life sciences research drives market growth
Funding for life sciences research is skyrocketing, supporting molecular research that elucidates the causes of disease and identifies biomarkers. The Novo Nordisk Foundation grant is $1.5 million Establish a mass spectrometry facility in University of Copenhagen This represents a major leap forward in protein research. As a result, increasing spending on proteomics and genomics research and development is driving market growth.
Various applications of protein labeling
Protein labeling applications span a wide range of functions. Cell-based assays provide valuable insight into molecular targets within cells and offer advantages in biological contexts. Fluorescent antibodies play an important role in clinical therapy and research in immunology, cell biology, and neuroscience.
Mass spectrometers are essential devices for the identification and quantification of compounds across a variety of disciplines, including proteomics. Immunological approaches include the study of the immune system and the application of immunological reagents as tools. Protein microarrays, a new proteomics technology, are rapidly gaining popularity in molecular biology and biochemistry.
Segment Insights: Key Drivers of Market Growth
-
In 2022, fluorescent proteins will dominate the reagent segment, simplifying in situ fusion expression by gene transfer into cells. This eliminated the need for recombinant protein purification, in vitro labeling, high-level heterologous production, and microinjection.
-
The fluorescence microscopy segment is expected to witness the fastest CAGR from 2023 to 2030, driven by the development of monomeric fluorescent proteins that can fluoresce in the orange to far-red bands of the visible light spectrum.
-
The in vitro labeling segment is expected to account for the largest revenue share in 2022 and exhibit the fastest CAGR during the forecast period. Its growth has been attributed to the simplicity associated with in vitro techniques and the availability of numerous commercial kits.
-
In 2022, North America It led the market with the highest revenue share. This advantage can be attributed to the presence of major manufacturers, increasing attention to proteomics research, advances in bioengineering technology, and greater adoption of protein-labeled products in disease diagnosis-related research.
Market trend
competitive environment
-
Company classification
-
strategy mapping
-
Company market position analysis, 2022
-
Company profile/list
-
overview
-
Financial performance (net revenue/sales/EBITDA/gross profit)
-
Product benchmarking
-
strategic initiatives
Company Profile
-
Thermo Fisher Scientific
-
Merck KGaA
-
PerkinElmer Co., Ltd.
-
Promega Co., Ltd.
-
F. Hoffman La Roche Co., Ltd.
-
LGC Co., Ltd.
-
new england bio lab
-
Lycall Co., Ltd.
-
GE Healthcare
-
Jena Bioscience GmbH
Analysis of market drivers
-
Increase in R&D expenses related to proteomics research
-
Increased adoption of bioengineering technologies
-
Increase in technological advancements in the market
Market restraint analysis
industry analysis tools
product business analysis
-
reagent
-
protein
-
enzyme
-
probe/tag
-
monoclonal antibody
-
kit
-
service
method business analysis
application business analysis
-
Cell-based assay
-
fluorescence microscope
-
immunological techniques
-
protein microarray
-
mass spectrometry
For more information about this report, please visit: https://www.researchandmarkets.com/r/vq6emj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
Media contact:
research and market
Laura WoodSenior Manager
press@researchandmarkets.com
For Eastern Standard Time office hours, please call +1-917-300-0470.
For USA/Canada Toll Free +1-800-526-8630
For GMT office hours, please call +353-1-416-8900.
US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716
logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
Source Research and Market
